Testing Archives - Page 21 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 12 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 17 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Laboratory/Patient Safety/Quality Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Lab Medicine Rounds - Insights
A Mayo Clinic podcast for physicians, laboratory professionals, and students hosted by Justin Kreuter, M.D., (the Bow Tie Bandit of Blood) and featuring trending topics from subject-matter experts. Note: Podcasts will not play back on...
Laboratory/Patient Safety - Insights
The following on demand education is related to Laboratory/Patient Safety, which is a key subfield within the medical laboratory science (MLS), that focuses on maintaining a safe environment for both laboratory personnel and patients.
Hot Topic Archives - Page 2 of 5 - Insights
Skip to Content MayoACCESS MayoLINK...
Leveraging the Laboratory - Insights
A Mayo Clinic podcast for administrators, outreach managers, and laboratory professionals hosted by Jane Hermansen, outreach manager at Mayo Clinic Laboratories, on how to best leverage and optimize the laboratory for patients, clients, and...
Leveraging Lessons from the Past - Insights
Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.
Present Approaches to Testing - Insights
Discussing current test applications that you can implement in your laboratory or practice today.
Managing Compliance in Preparation for 2025 Updates - Insights
With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans.
Five Steps to Optimizing Your Outreach Test Menu - Insights
With changes in technology, medical practice, and market trends, and the expansion of health system services, the laboratory test menu can be ever in flux. It is essential that the laboratory test menu keeps up with trends, remaining...
Creative approaches to laboratory outreach staffing - Insights
In a constrained staffing environment, how can an outreach program effectively meet customer needs? Through creativity, collaboration, and shared services, there can be multiple solutions to provide the support needed by the laboratory...
Memorial Day Specimen Shipping Alert - Insights
Due to the Memorial Day holiday (recognized on Monday, May 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please note the...
Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D. - Insights
John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent.
Memorial Day 2024 Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories specimen pickup and delivery schedules will be altered due to the upcoming Memorial Day holiday on Monday, May 27, 2024. To ensure specimen stability and prevent delays, follow the guidelines below outlined for...
Labor Day Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories specimen pickup and delivery schedules will be altered due to the upcoming holiday. To ensure specimen stability and prevent delays, follow these guidelines.
Direct Ethanol Biomarker Testing: PETH - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' new direct biomarker test for alcohol consumption. PETH is a blood test with a window of detection of about two to four weeks — compared with five days for urine-based screening for...
Whole genome sequencing streamlines diagnosis - Insights
Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC, explain how Mayo Clinic Laboratories' whole genome sequencing provides comprehensive information for rapid diagnosis of hereditary disorders.
RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D. - Insights
Lisa Rimsza, M.D., explains how Mayo Clinic Laboratories' unique PM3CX test can accurately determine subtypes of large B-cell lymphoma. Precise diagnosis is critical to choosing appropriate chemotherapy.
Neurofilament Light Chain (NFLC) - Insights
Alicia Algeciras, Ph.D., describes Mayo Clinic Laboratories’ new blood test to detect NFLC, or neurofilament light chain protein. NFLC is a biomarker for several neurodegenerative conditions. The new assay can determine if a patient’s...
Results report simplifies urine test interpretation: John Lieske, M.D. - Insights
John Lieske, M.D., explains why it's now easier for clinicians to pull information from Mayo Clinic Laboratories' supersaturation test report. An updated format summarizes complex information to help guide the treatment of kidney stones.
Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D. - Insights
Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal...
Patients with elevated LDL or "bad" cholesterol face even greater risk if their levels of small dense LDL cholesterol are also high. Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D., explain how Mayo Clinic Laboratories' sdLDL-c assay...
NELL-1 [Test in Focus] - Insights
Sanjeev Sethi, M.D., Ph.D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic certainty and...
Stiff-Person/PERM Evaluation - Insights
Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' stiff-person assay provides comprehensive evaluation for individuals on the spectrum of stiff-person syndrome. In addition to guiding treatment decisions, the assay...
Inflammatory Bowel Disease: IBDP2 - Insights
In this test specific episode of the "Answers From the Lab" podcast, Melissa Snyder, Ph.D., explains how IBDP2, when used after first-line testing has failed, can distinguish between ulcerative colitis and Crohn’s disease.
A clearer path through a difficult diagnosis - Insights
The fourth episode of “Life of a Specimen” video series explores the diagnosis enabled by antibody testing on Joy Carol’s cerebrospinal cord fluid and how her test result illuminated a path forward.
CPT codes and LOINC update: February 2024 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of February.
CPT codes and LOINC update: June 2024 - Insights
This page includes updates posted to Mayo Clinic Labs during the month of June.
CPT codes and LOINC update: January 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of January.
CPT codes and LOINC update: March 2021 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of March.
CPT codes and LOINC update: February 2022 - Insights
CPT Code updates posted to mayocliniclabs.com during the month of February
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory 2023 - Insights
Mayo Clinic Laboratories’ Outreach Conference was held Sept. 26-27, 2023, in Chicago. “Leveraging the Laboratory: Dimensions of Outreach” provides innovative views into all aspects of health system laboratory outreach programs.
Lab medicine is an ever-evolving field, and staying up to date can be a challenge. Mayo Clinic Laboratories' podcasts are designed to share the information you need to know about the latest developments in laboratory diagnostics.
Colorectal panel provides detailed cancer information - Insights
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new colorectal cancer panel. The assay covers more genes to better inform decision-making about prognosis, targeted therapies and a hereditary cancer syndrome.
Extended Spectrum Beta Lactamase Testing - Insights
Audrey Schuetz, M.D., provides a detailed overview of Mayo Clinic Laboratories’ new culture-based extended spectrum beta lactamase (ESBL) testing. Used to screen for the presence of multi-drug resistant gram-negative bacteria in donor stool...
How an ex-NFL Linebacker Overcame His Greatest Opponent, Amyloidosis - Insights
Matt Millen, ex-pro NFL player, who played on four Super Bowl-winning teams underwent a nearly six-year medical journey in search for answers. Finally, he was diagnosed with amyloidosis using a new testing methodology at Mayo Clinic.
Diagnostic ecosystem boosts access to timely Alzheimer's disease testing - Insights
Mayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer's disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The testing suite exemplifies Mayo Clinic...
Preparation of Platelet-Poor Plasma for Special Coagulation Testing - Insights
In this months "Hot Topic," Christopher Desens, MLS(ASCP) discusses the preparation of platelet-poor plasma for coagulation testing.
What's New in Health Care Reform: Jan. 9 - Insights
Top highlights include: new research shows sugar substitutes are not healthier than real sugar, how light therapy helps Minnesotans during winter, what you must know about Parkinson's disease, new law requires hospitals post prices online,...
Lab discoveries fuel updates for autoimmune movement disorders test - Insights
Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
Detecting danger: Dan O'Bryan - Insights
Dan O’Bryan didn’t think his dizziness and lightheadedness were anything to worry about. Nearly 100 miles away, the team at Mayo Clinic that was remotely monitoring Dan’s heart could see the truth.
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights
In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...